VIM and lung carcinoma: These findings are in accordance with previous studies demonstrating that IL-6 treatment can activate p-STAT3, decrease E-cadherin expression, and increase vimentin expression in other cancer cell lines, such as lung cancer cell lines33 and breast cancer cell lines.34